Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
5.33
+0.07 (1.33%)
Dec 5, 2025, 4:00 PM EST - Market closed
Candel Therapeutics Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Candel Therapeutics stock have an average target of 19.43, with a low estimate of 7.00 and a high estimate of 25. The average target predicts an increase of 264.54% from the current stock price of 5.33.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Candel Therapeutics stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 0 | 0 | 0 | 1 | 1 | 1 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 6 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $25 → $24 | Strong Buy | Maintains | $25 → $24 | +350.28% | Nov 14, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Initiates $15 | Buy | Initiates | $15 | +181.43% | Oct 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $23 | Strong Buy | Reiterates | $23 | +331.52% | Sep 29, 2025 |
| B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $13 → $7 | Strong Buy → Hold | Downgrades | $13 → $7 | +31.33% | Sep 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +331.52% | Jun 30, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.42
from -1.74
EPS Next Year
-1.01
from -0.42
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.43 | -0.53 | |
| Avg | -0.42 | -1.01 | |
| Low | -0.42 | -1.43 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.